Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Number of Procedure Conducted, Sales Volume & ASP by Implant Materials The global cranial implants market will witness a robust CAGR of 6.63%, valued at $1.08 billion in 2021, expected to appreciate and reach $1.94 billion by 2030, confirms Strategic Market Research. North America held the largest market share and is expected to continue witnessing growth at a CAGR of around 5.5% during the projected period. Cranial Implants are small implants which are used to stabilize prostheses that replace missing craniofacial elements such as the ears, nose, orbits, and eyes. Cranial implants are mostly used in Maxillofacial surgery, neurosurgery, and cranioplasty. According to the American Society of Plastic Surgeons, more than 256,000 Maxillofacial surgeries were performed in 2020. Cranial Implants are found to have a lot of benefits. Cranial Implants are customized to the anatomy of the individual patient. Because they are constructed with utmost accuracy, delivering exact size and shape as per the patient’s demand, surgeons may put these implants and perform the procedure with relative ease. Cranial implants are made using titanium-aluminum alloy, which has high strength, low thermal expansion, high corrosion resistance, excellent biocompatibility, good osseointegration, and low thermal conductivity, giving the user strong and stable protection. Cranial implants allow doctors to restore the defect as best as possible while also reducing the risk of complications, operating and recovery time. Market Drivers - Increasing Prevalence of Traumatic Brain Injuries, Increased Geriatric Population, Growing Demand for Customised Cranial Implants The growing number of reported cases for traumatic brain injuries (TBI) is currently driving the market’s growth. A traumatic brain injury may be caused due to a bump to the head or a penetrating injury to the head. There are three main causes of traumatic brain injuries – mild TBI or concussion, moderate TBI, & severe TBI. The BIAA (Brain Injury Association of America) reported that about 2.8 million Americans sustain a TBI annually, with about 280,000 of them requiring hospitalization. 1 in every 60 people, or 5.3 million Americans, has a TBI-related disability. The rising senior population in the world led to an increase in the number of brain diseases (like Alzheimer’s and Parkinson’s disease) reported globally. The rise in the number of reported brain disease cases causes demand for cranial implants to increase, propelling the market growth. According to the Parkinson’s Foundation, nearly 1 million Americans live with Parkinson’s disease, and the number is expected to grow to 1.2 million by 2030. Approximately 60,000 Americans are diagnosed with Parkinson’s disease each year. The rise in the demand for cranial implants has helped propel market growth. A custom-made cranial implant can replace the patient’s skull and can be modified as per the patient’s CT scan and MRI scan to fit him perfectly. 3D printed implants are recently becoming popular for cranial implants as the implant can be designed on software and printed to perfectly fit the patient’s need. Cranial implants are mainly used to treat craniosynostosis. According to Johns Hopkins Medicine, craniosynostosis affects one in 2200 babies. If left untreated, craniosynostosis can cause head deformity, which can be severe and permanent, seizures, and increased pressure on the brain. Cranial implants can also be used to treat neurological disorders like depression. In October 2021, researchers discovered that the jolts from a customized cranial implant provided temporary and immediate relief to a patient who was suffering from severe depression. Market Restraints - Increased Rate of Implant Failure, Stringent Government Regulations As most cranial implantation surgeries are conventional (i.e., the doctor performs the whole surgery by hand), implant failure rates drastically increase. This causes many patients to prefer alternate options, hindering market growth. The government of various countries impose stringent regulations on the procurement and use of cranial implants, which causes surgeons to prefer alternate treatment methods, which can impede the global cranial implants market growth. Market Opportunities - New Applications Recently, newer applications for cranial implants have been discovered, which could boost the global cranial implant market trends. Cranial implants can be used in cranioplasty, neuroplastic surgery, prosthesis, anaplastology, Maxillofacial surgery, and cerebral hemodynamics to treat traumatic brain injury and ischemic diseases (like cerebral ischemia) and ischemic stroke), brain tumors, and craniosynostosis using bone grafts and skull contours. According to the CDC, nearly 87% of all strokes reported are ischemic strokes, while according to the National Brain Tumour Society, an estimated 700,000 people live with a primary brain tumor in the United States of America. At the same time, approximately another 89,000 more will be diagnosed with a primary brain tumor in 2022.With these promising statistics the Cranial Implants market is poised to propel at a distinguished pace. Market Analysis Of Different Segments Covered in the Report Based on Product Customized Non-Customized Based on Material Polymer Ceramic Metal Based on End-Use Hospitals Neurosurgical Centres Regional Coverage Analysis North America United States of America Canada Europe Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific LAMEA Brazil Mexico Colombia Argentina South Africa Saudi Arabia United Arab Emirates Rest of LAMEA Product Analysis & Insights The customized cranial implants segment is estimated to significantly lead the overall market during the forecast period, with around 78%. The rise in market share can be attributed to surgeons’ increasing demand for product as each skull damage is unique and requires particular implants. The rising occurrence of the brain tumors due to genetic diseases and irregular lifestyles, together with rising wounds, injuries, and, road accidents is predicted to increase demand and influence segment expansion. As stated by the American Society for Clinical Oncology, around 25,000 adults are expected to have brain and spinal cord tumors in 2022 in the United States of America, and around 308,000 adults will have brain and spinal cord tumors worldwide. Material Analysis & Insights Over the projection period, the polymer-material is predicted to have the largest global cranial implant market size. The most commonly utilized substance for manufacturing cranial implants is polymer [like polyetheretherketone (PEEK)]. It comes in the powder or liquid form, which are blended to fit into shapes of cranial deformities during surgery. According to a study, biomechanical analysis of PEEK cranial implant showed that the maximal von Mises stress is 8.15 MPa, von Mises strain is 0.002, and deformation is 0.18 mm, which is extremely low and showed the load-bearing capability of the implant. The Ceramic-material segment is predicted to have the greatest CAGR over the projection period. The use of light and sound in the brain has significant diagnostic and therapeutic effects. Ultrasound is known as an effective treatment for neurological illnesses like Parkinson’s and Alzheimer’s, which are on the rise. According to the Alzheimer’s Association, 6.5 million Americans live with Alzheimer’s disease, and the number of reported cases is expected to increase to 13 million by 2030. According to Johns Hopkins Medicine, amyotrophic lateral sclerosis affects more than 30,000 Americans, with 5000 new cases diagnosed every year. The ability of ceramic cranial implants to efficiently transmit light and ultrasound to the brain and the rise in neurological diseases is driving market expansion. End-Use Analysis & Insights Because of the specialized and individualized treatment of patients, the ‘neurosurgery centers’ segment is the largest global cranial implants market segment in terms of end use, with a share of around 71%. Furthermore, improved outcomes in contrast to hospitals are growing demand for neurosurgical institutes. Also, neurosurgical centers guarantee that patients receive tailored care, resulting in a better patient experience. According to the National Health Service, there are 25 neurosurgical centers in England that cover populations of between 1 million to 3.5 million. According to KPMG, there are 2400 neurological and neurosurgical clinics in the United States of America. The ‘hospitals’ segment is the fastest-growing in the market due to the availability of experienced neurosurgeons and individuals’ increasing disposable money. The increase in brain injuries, abnormalities, and traumas necessitates several therapy sessions, which is expected to drive category expansion. According to the Brain Injuries Association of Connecticut, 2.8 million Americans sustain a brain injury every year, with a brain injury occurring every 21 seconds. According to the Centre for Mental Health UK, around 160,000 people are hospitalized each year as they sustain a brain injury. Additionally, increasing healthcare infrastructure in emerging nations and increased acceptance of innovative goods will likely support segment growth. Regional Analysis & Insights North America held the largest market share and is expected to continue witnessing substantial growth at a rate of around 5.5% during the projected period. The prevalence of trauma & brain cancer, the adoption of technologically sophisticated technologies, and increased healthcare spending by regional governments can be attributed to the growth of the market in this region. According to the Canadian Cancer Society, around 3200 Canadians will be diagnosed with brain and spinal cord cancer, out of which 1850 will be men, and 1350 women in 2022. According to the National Cancer Institute, 25,050 new cancer cases will be diagnosed in 2022. Asia-Pacific is predicted to grow the fastest due to an increase in neurological illnesses and government efforts and awareness campaigns by non-governmental organizations. The presence of many industry participants in economies such as Japan, China, and India is pushing segment expansion significantly. In addition, rising cancer rates in these countries are expected to assist in fostering the growth of this segment. According to the IACR (International Association of Cancer Registries), around 166,000 new cancer cases were reported in 2020, where 31,000 new cases (or 18.67% of new cases) were reported in India, and 80,000 new cases (or 48.19% of new cases) were reported in China. Cranial Implants Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 1.08 billion The revenue forecast in 2030 USD 1.94 billion Growth rate CAGR of approximately 6.63% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Material, By End-Use, and By Region By Product Customized, Non-Customised By Material Polymer, Ceramic, Metal By End-Use Hospitals, Neurosurgical Centres By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Germany, United Kingdom, France, Italy, Spain, Canada, China, Japan, India, Australia, South Korea, Brazil, Mexico, Colombia, Argentina, South Africa, Saudi Arabia, United Arab Emirates Company Usability Profiles B. Braun Melsungen AG, DePuy Synthes (a Johnson & Johnson subsidiary), KLS Martin Group, Stryker Corporation, ZIMMER BIOMET HOLDINGS INC, Acumed, Synimed, evonos GmbH & Co. KG, Medartis Holding AG, Renishaw PLC, Kelyiniam Global, Inc., Xilloc Medical B.V., Anatomics Pty Ltd., BioArchitects, Bioplate Inc, EUROS SAS Global Cranial Implants Market Competitive Landscape Analysis The market is moderately competitive, with several key market players. Some major players are launching new devices to maintain their market share, while others employ certain strategies like mergers & acquisitions. The major competitors in the market are: B. Braun Melsungen AG DePuy Synthes (a Johnson & Johnson subsidiary) KLS Martin Group Stryker Corporation ZIMMER BIOMET HOLDINGS INC Acumed Synimed evonos GmbH & Co. KG Medartis Holding AG Renishaw PLC Kelyiniam Global, Inc. Xilloc Medical BV. Anatomics Pty Ltd. BioArchitects Bioplate Inc EUROS SAS Recent Developments In May 2022, Medartis Holding AG announced the acquisition of Nextremity Solutions, Inc., for USD 100 million. Medartis Holding believes that the acquisition will accelerate its US extremeties business by obtaining access to a comprehensive product pipeline, strong relationships with American design surgeons, and an experienced R&D team. In December 2021, Kelyniam Global, Inc. announced its licensing agreement with Fin-Ceramica Faenza spa to market its hydroxyapatite patient-specific cranial implant. Kelyniam Global believes that the partnership will allow the company to further develop its CustomizedBone Cranial Implant in the United States of America. In October 2021, KLS Martin Group announced the integration of the business operations of five companies under it – the Karl Leibinger Medizintechnik GmbH and Co. KG, Rudolf Buck GmbH, Mondeal Medical Systems GmbH, Gebrüder Martin GmbH & Co. KG and KLS Martin GmbH & Co. – to form a single company. KLS Martin Group believes that the reorganization of the current structure can allow it to withstand the growing regulatory requirements. In October 2020, Acumed announced its merger with Osteomed. Acumed and Osteomed believe that the merger will allow both organizations to deliver comprehensive solutions to assist their customers in achieving optimal restoration of function. In October 2020, DePuy Synthes (a Johnson & Johnson subsidiary) announced the launch of its Radial Head Replacement System in the United States of America for patients possesing destabilizing radial head fractures that can’t be repaired. DePuy Synthes believes that introducing the Radial Health Replacement System can further expand its offering in extremities and allow surgeons to save time in the operating room. List of Various Cranial Implants that Key Market Leaders Develop Product Function Key Player CeSpace Titanium Treatment of degenerative discs and instabilities in the cervical spine. B. Braun Melsungen AC MatrixNEURO Assists in Accurate Cranial Reconstruction. DePuy Synthes (a Johnson & Johnson subsidiary) Universal Titanium Mesh Reduction of Palpability. Stryker Corporation HTR-PEKK Patient-Matched Cranial Implant High tensile strength for better protection. Zimmer Biomet Holdings, Inc. Xilloc 3D-Printed Titanium Cranial Implant Biocompatible and has antibacterial properties. Xilloc Medical BV. Frequently Asked Question About This Report Which region has the largest share in market? North America had the largest market share. Who are the crucial players in market? The major competitors in the market are B. Braun Melsungen AG, DePuy Synthes (a Johnson & Johnson subsidiary), KLS Martin Group, Stryker Corporation, ZIMMER BIOMET HOLDINGS INC, Acumed, Synimed, evonos GmbH & Co. KG, Medartis Holding AG, Renishaw PLC, Kelyiniam Global, Inc., Xilloc Medical B.V., Anatomics Pty Ltd., BioArchitects, Bioplate Inc, and EUROS SAS. How big is the cranial implants market? The global cranial implants market will witness a robust CAGR of 6.63%, valued at $1.08 billion in 2021, expected to appreciate and reach $1.94 billion by 2030. What is the cranial implants market growth? The cranial implants market growth is 6.63% from 2020 to 2030. Which region held the highest growth rate in market? Asia-Pacific had the highest market growth rate. Sources https://www.parkinson.org/understanding-parkinsons/statistics https://www.hopkinsmedicine.org/health/conditions-and-diseases/craniosynostosis https://www.cdc.gov/stroke/facts.htm https://braintumor.org/brain-tumors/about-brain-tumors/brain-tumor-facts https://www.alz.org/alzheimers-dementia/facts-figures https://corporatefinance.kpmg.us/insights/2020/neurology-ma-overview.html https://www.biausa.org/public-affairs/public-awareness/brain-injury-awareness 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key Material insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Cranial Implants Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Material Outlook 4.1 Market Snapshot 4.2 Cranial Implants Market 4.2.1 Market, 2020 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021-2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Market, By Product, 2021-2030 (USD Million) 4.5 By Material Business Analysis 4.5.1 Market, By Material, 2021-2030 (USD Million) 4.6 End-User Business Analysis 4.6.1 Market, By End-User, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. End-User Analysis 5.11.1. Trends in End-User (2014-2020) 5.11.2. Trends in End-User (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Customized 7.3.1. Customized, 2021-2030 (USD Million) 7.4. Non-Customized 7.4.1. Non-Customized Market, 2021-2030 (USD Million) 8. Market: By Material Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Polymer 8.3.1. Polymer Market, 2021-2030 (USD Million) 8.4. Ceramic 8.4.1. Ceramic Market, 2021-2030 (USD Million) 8.5. Metal 8.5.1. Metal Market, 2021-2030 (USD Million) 9. Market: By End-User Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Neurosurgical Centres 9.3.1. Neurosurgical Centres Market, 2021-2030 (USD Million) 9.4. Hospitals 9.4.1. Hospitals Market, 2021-2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021-2030 (USD Million) 10.1.2. North America Market, By Material, 2021-2030 (USD Million) 10.1.3. North America Market, by End-User, 2021-2030 (USD Million) 10.1.4. North America Market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. Market, By Material, 2021-2030 (USD Million) 10.1.4.1.3. U.S. Market, by End-User, 2021-2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada Market, By Material, 2021-2030 (USD Million) 10.1.4.2.3. Canada Market, by End-User, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021-2030 (USD Million) 10.2.2. Europe Market, By Material, 2021-2030 (USD Million) 10.2.3. Europe Market, by End-User, 2021-2030 (USD Million) 10.2.4. Europe Market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. Market, By Material, 2021-2030 (USD Million) 10.2.4.1.3. U.K. Market, by End-User, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany Market, By Material, 2021-2030 (USD Million) 10.2.4.2.3. Germany Market, by End-User, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021-2030 (USD Million) 10.2.4.3.2. France Market, By Material, 2021-2030 (USD Million) 10.2.4.3.3. France Market, by End-User, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By Material, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by End-User, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific Market, By Material, 2021-2030 (USD Million) 10.3.3. Asia Pacific Market, by End-User, 2021-2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021-2030 (USD Million) 10.3.4.1.2. China Market, By Material, 2021-2030 (USD Million) 10.3.4.1.3. China Market, by End-User, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021-2030 (USD Million) 10.3.4.2.2. India Market, By Material, 2021-2030 (USD Million) 10.3.4.2.3. India Market, by End-User, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan Market, By Material, 2021-2030 (USD Million) 10.3.4.3.3. Japan Market, by End-User, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea Market, By Material, 2021-2030 (USD Million) 10.3.4.4.3. South Korea Market, by End-User, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By Material, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by End-User, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021-2030 (USD Million) 10.4.2. Latin America Market, By Material, 2021-2030 (USD Million) 10.4.3. Latin America Market, by End-User, 2021-2030 (USD Million) 10.4.4. Latin America Market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil Market, By Material, 2021-2030 (USD Million) 10.4.4.1.3. Brazil Market, by End-User, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico Market, By Material, 2021-2030 (USD Million) 10.4.4.2.3. Mexico Market, by End-User, 2021-2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By Material, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by End-User, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021-2030 (USD Million) 10.5.2. MEA Market, By Material, 2021-2030 (USD Million) 10.5.3. MEA Market, by End-User, 2021-2030 (USD Million) 10.5.4. MEA Market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 B. BRAUN MELSUNGEN AG 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. DePuy Synthes (a Johnson & Johnson subsidiary) 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. KLS Martin Group 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. Stryker Corporation 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. ZIMMER BIOMET HOLDINGS INC 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Acumed 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. SYNIMED 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Evonos GmbH & Co. KG 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Medartis Holding AG 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Renishaw PLC 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Kelyiniam Global, Inc 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Xilloc Medical BV. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Anatomics Pty Ltd. 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. BioArchitects 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. Bioplate Inc 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. EUROS SAS 11.16.1. Company overview 11.16.2. Financial performance 11.16.3. Product Portfolio Analysis 11.16.4. Business Strategy & Recent Development List of Tables (59 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Customized, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Non-Customized, BY REGION, 2021-2030 (USD Million) TABLE 4. Market, By Material, 2021-2030 (USD Million) TABLE 5. Market FOR Polymer, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Ceramic, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Metal, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, BY END-USER, 2021-2030 (USD Million) TABLE 9. Market FOR Neurosurgical Centres, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 11. Market, BY REGION, 2021-2030 (USD Million) TABLE 12. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, By Material, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA Market, BY END-USER, 2021-2030 (USD Million) TABLE 16. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 17. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 18. EUROPE Market, By Material, 2021-2030 (USD Million) TABLE 19. EUROPE Market, BY END-USER, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC Market, By Material, 2021-2030 (USD Million) TABLE 23. ASIA-PACIFIC Market, BY END-USER, 2021-2030 (USD Million) TABLE 24. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 26. LAMEA Market, By Material, 2021-2030 (USD Million) TABLE 27. LAMEA Market, BY END-USER, 2021-2030 (USD Million) TABLE 28. B. BRAUN MELSUNGEN AG.: COMPANY SNAPSHOT TABLE 29. B. BRAUN MELSUNGEN AG.: OPERATING SEGMENTS TABLE 30. DePuy Synthes (a Johnson & Johnson subsidiary): COMPANY SNAPSHOT TABLE 31. DePuy Synthes (a Johnson & Johnson subsidiary): OPERATING SEGMENTS TABLE 32. KLS Martin Group: COMPANY SNAPSHOT TABLE 33. KLS Martin Group: OPERATING SEGMENTS TABLE 34. Stryker Corporation: COMPANY SNAPSHOT TABLE 35. Stryker Corporation: OPERATING SEGMENTS TABLE 36. ZIMMER BIOMET HOLDINGS INC: COMPANY SNAPSHOT TABLE 37. ZIMMER BIOMET HOLDINGS INC: OPERATING SEGMENTS TABLE 38. Acumed: COMPANY SNAPSHOT TABLE 39. Acumed: OPERATING SEGMENTS TABLE 40. SYNIMED: COMPANY SNAPSHOT TABLE 41. SYNIMED: OPERATING SEGMENTS TABLE 42. Medartis Holding AG: COMPANY SNAPSHOT TABLE 43. Medartis Holding AG: OPERATING SEGMENTS TABLE 44. Renishaw PLC.: COMPANY SNAPSHOT TABLE 45. Renishaw PLC.: OPERATING SEGMENTS TABLE 46. Kelyiniam Global, Inc: COMPANY SNAPSHOT TABLE 47. Kelyiniam Global, Inc: OPERATING SEGMENTS TABLE 48. Evonos GmbH & Co. KG: COMPANY SNAPSHOT TABLE 49. Evonos GmbH & Co. KG: OPERATING SEGMENTS TABLE 50. Xilloc Medical BV.: COMPANY SNAPSHOT TABLE 51. Xilloc Medical BV.: OPERATING SEGMENTS TABLE 52. Anatomics Pty Ltd.: COMPANY SNAPSHOT TABLE 53. Anatomics Pty Ltd.: OPERATING SEGMENTS TABLE 54. BioArchitects: COMPANY SNAPSHOT TABLE 55. BioArchitects: OPERATING SEGMENTS TABLE 56. Bioplate Inc: COMPANY SNAPSHOT TABLE 57. Bioplate Inc: OPERATING SEGMENTS TABLE 58. EUROS SAS: COMPANY SNAPSHOT TABLE 59. EUROS SAS: OPERATING SEGMENTS List of Figures (21 Figures) Figure 1 Cranial Implants Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market Product-Based Estimation Figure 6 Top 16 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Cranial Implants, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Cranial Implants, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Material, 2019 vs 2025 (USD Million) Figure 12 Market Share, By End-User, 2019 vs 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Neurosurgical Centres to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 16 Customized cranial implants to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 17 Polymer-material to Witness Higher CAGR in the Market for Material Segment during Forecast Period. Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview